AI-Assisted Structured Guidance for Narrative Review Writing
25 de mayo de 2026 actualizado por: Zhongshan Ophthalmic Center, Sun Yat-sen University
Effect of Artificial Intelligence-Assisted Structured Guidance on the Quality of Narrative Literature Reviews Among Medical Postgraduate Students: A Randomized Controlled Educational Study
This randomized, parallel-group, assessor-blinded educational study will evaluate whether one session of AI-assisted structured guidance improves the quality of narrative literature reviews written by medical postgraduate students.
A total of 102 students enrolled in an academic writing course will be randomly assigned to either an AI-assisted structured guidance group or a free AI use group.
Both groups may use AI tools under academic integrity requirements and will complete a narrative literature review according to the same course requirements.
The guidance group will receive one structured guidance session approximately two weeks before final submission.
The session will be based on the six dimensions of the Scale for the Assessment of Narrative Review Articles (SANRA).
The primary outcome is the final SANRA total score of the submitted narrative literature review.
Descripción general del estudio
Estado
Aún no reclutando
Intervención / Tratamiento
Descripción detallada
Generative artificial intelligence is increasingly used by medical students and postgraduate trainees for literature searching, summarization, outlining, and academic writing. However, free use of AI may be associated with inaccurate information, unsupported statements, fabricated references, and inadequate academic judgment. This study is designed to evaluate whether structured guidance can improve the quality and academic integrity of AI-assisted narrative review writing.
Participants will be medical postgraduate students enrolled in an academic writing course. After informed consent and baseline data collection, participants will be randomized in a 1:1 ratio to an AI-assisted structured guidance group or a free AI use group. Both groups will complete a narrative literature review of approximately 2,000 Chinese characters according to the same course requirements and may use AI tools under academic integrity requirements.
Participants in the AI-assisted structured guidance group will receive one structured guidance session approximately two weeks before final submission. The session will be based on the six SANRA dimensions: explanation of the importance of the article, statement of aims or questions, description of the literature search, reference support for key statements, scientific reasoning, and appropriate presentation of data and content. The instructor will provide directional and methodological feedback but will not directly write or edit the students' text line by line. Participants in the free AI use group will complete the review according to the same course requirements without the structured guidance session.
After submission, all narrative reviews will be anonymized and assessed by independent outcome assessors blinded to group allocation. The primary outcome is the final SANRA total score. Secondary outcomes include SANRA item scores, multiple-source academic writing self-efficacy, and reference authenticity error rate.
Tipo de estudio
Intervencionista
Inscripción (Estimado)
102
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Guangming Jin
- Número de teléfono: +86-13560035613
- Correo electrónico: jinguangming@gzzoc.com
Ubicaciones de estudio
-
-
Guangdong
-
Guangzhou, Guangdong, Porcelana, 510060
- Zhongshan Ophthalmic Center, Sun Yat-sen University
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Master's students enrolled in the Academic Standards and Thesis Writing course.
- Willing to participate in this study, able to understand the study procedures and randomization arrangement, and able to provide written informed consent.
- Able to complete literature searching, use AI tools, and complete online questionnaires.
Exclusion Criteria:
- Students who have confirmed withdrawal from the course, suspension of study, long-term leave, or other known objective reasons that prevent participation in subsequent major teaching activities and study procedures.
- Students who have participated in pilot testing, intervention material development, assessment training, or data processing related to this study.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: AI-Assisted Structured Guidance Group
Participants in this group will complete a narrative literature review according to the same course requirements as the control group.
They may use AI tools under academic integrity requirements and will additionally receive one structured guidance session approximately two weeks before final submission.
|
A single structured guidance session delivered approximately two weeks before final submission.
The session is based on the six SANRA dimensions and provides directional and methodological feedback on narrative review writing and appropriate AI use, without direct writing or line-by-line editing of students' text.
Participants may use AI tools freely under academic integrity requirements while completing the narrative literature review.
Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.
|
|
Comparador activo: Free AI Use Group
Participants in this group will complete a narrative literature review according to the same course requirements and may use AI tools under academic integrity requirements.
They will not receive the structured guidance session during the study period.
|
Participants may use AI tools freely under academic integrity requirements while completing the narrative literature review.
Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Final SANRA Total Score
Periodo de tiempo: Week 2
|
The quality of the final narrative literature review will be assessed using the Scale for the Assessment of Narrative Review Articles (SANRA).
The SANRA total score ranges from 0 to 12, with higher scores indicating better quality of the narrative review.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
SANRA Item 1 Score: Importance of the Article
Periodo de tiempo: Week 2
|
This outcome assesses SANRA item 1, which evaluates whether the importance of the narrative review article is adequately explained.
The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 2 Score: Aims or Questions
Periodo de tiempo: Week 2
|
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described.
The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 3 Score: Literature Search Description
Periodo de tiempo: Week 2
|
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described.
The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 4 Score: Referencing
Periodo de tiempo: Week 2
|
At final submission of the narrative literature review; assessment completed within 4 weeks after final submission.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 5 Score: Scientific Reasoning
Periodo de tiempo: Week 2
|
This outcome assesses SANRA item 5, which evaluates whether the scientific reasoning is based on appropriate evidence.
The item score ranges from 0 to 2, with higher scores indicating better scientific reasoning.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 6 Score: Data and Content Presentation
Periodo de tiempo: Week 2
|
This outcome assesses SANRA item 6, which evaluates whether data and content are presented appropriately.
The item score ranges from 0 to 2, with higher scores indicating better presentation.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
Change From Baseline in Multiple-Source Academic Writing Self-Efficacy Score
Periodo de tiempo: Baseline and Week 2
|
Multiple-source academic writing self-efficacy will be assessed using an adapted 8-item Multiple-Source Academic Writing Self-Efficacy Scale.
The change from baseline to final submission will be analyzed.
Higher scores indicate greater self-efficacy in integrating multiple sources for academic writing.
|
Baseline and Week 2
|
|
Reference Authenticity Error Rate
Periodo de tiempo: Week 2
|
The proportion of references with authenticity errors will be calculated for each submitted narrative literature review.
References will be verified using available bibliographic information such as DOI, PMID, title, authors, PubMed, CrossRef, Web of Science, Google Scholar, journal websites, or publisher websites.
A higher error rate indicates poorer reference authenticity.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de junio de 2026
Finalización primaria (Estimado)
1 de agosto de 2026
Finalización del estudio (Estimado)
1 de septiembre de 2026
Fechas de registro del estudio
Enviado por primera vez
25 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
25 de mayo de 2026
Publicado por primera vez (Actual)
1 de junio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
1 de junio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
25 de mayo de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- IIT2026064
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Descripción del plan IPD
Individual participant data will not be shared because the study involves students' coursework, questionnaires, AI use declarations, and writing-related educational data.
These data may contain potentially identifiable information even after de-identification.
Only aggregated results will be reported in publications or academic presentations.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .